Your email has been successfully added to our mailing list.

×
0.200807847663012 0.192537026351221 0.490671282939027 0.327370648201577 0.269474899019042 0.175226005000962 0.339873052510098 0.187343719946143
Stock impact report

Results from Influenza Challenge Study Published in Lancet Infectious Diseases

Vaxart, Inc. (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
Company Research Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that the results from its H1 influenza oral tablet vaccine challenge study were published in the Lancet Infectious Diseases, January 21, 2020 and currently available at doi.org/10.1016/S1473-3099(19)30584-5. Topline results had been reported previously.  The study demonstrated a single dose with the Vaxart oral tablet H1 influenza vaccine was well tolerated and provided statistically significant protection against H1 influenza infection in the human challenge model.   Efficacy results trended favorably when compared to Fluzone, an injectable quadrivalent influenza vaccine (QIV) and the active comparator in the study. “If the results of the oral H1N1 influenza vaccine in this clinical trial can be reproduced with a quadrivalent mixture of strains this would rev Show less Read more
Impact Snapshot
Event Time:
VXRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VXRT alerts
Opt-in for
VXRT alerts

from News Quantified
Opt-in for
VXRT alerts

from News Quantified